Gilead Sciences, Inc.
NASDAQ:GILD
Overview | Financials
Company Name | Gilead Sciences, Inc. |
Symbol | GILD |
Currency | USD |
Price | 92.63 |
Market Cap | 115,323,423,700 |
Dividend Yield | 4.46% |
52-week-range | 62.07 - 98.9 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Daniel P. O'Day |
Website | https://www.gilead.com |
An error occurred while fetching data.
About Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD